Skip to main content
Livermore
Livermore
ZHEN

Lisanti Capital Growth, LLC

SEC CIK
0001424467
Latest filing
Aug 10, 2026

The latest 13F from Lisanti Capital Growth, LLC covers Q2 2026 (filed Aug 10, 2026): 109 long positions worth $454.6M. The top 10 holdings make up 19.1% of the portfolio, and the largest is Hinge Health, Inc. (HNGE) at 2.5%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
50
Est. +$179.9M
Added
18
Est. +$36.7M
Reduced
37
Est. −$111.3M
Sold out
44
Est. −$162.7M

Top 5 holdings

Share of this quarter's portfolio value

  1. HNGEHinge Health, Inc.
    2.5%$11.5MHistory
  2. BTSGBrightSpring Health Services, Inc.
    2.4%$10.8MHistory
  3. XMTRXometry, Inc.
    2.1%$9.74MHistory
  4. SEISolaris Energy Infrastructure, Inc.
    2.0%$9.23MHistory
  5. CORTCorcept Therapeutics Inc
    1.8%$7.97MHistory

Share of portfolio

Top 5 holdings and the other 104 positions, by share of portfolio value

  1. HNGE2.5%
  2. BTSG2.4%
  3. XMTR2.1%
  4. SEI2.0%
  5. CORT1.8%
  6. Other 104 positions89.2%

Biggest buys

New and added positions, by estimated amount bought

  1. XMTRXometry, Inc.
    +$9.74MNewHistory
  2. CORTCorcept Therapeutics Inc
    +$7.97MNewHistory
  3. ALGMAllegro Microsystems, Inc.
    +$7.51MNewHistory
  4. CVLTCommvault Systems Inc
    +$7.04MNewHistory
  5. ADPTAdaptive Biotechnologies Corp
    +$6.97MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. XMTRXometry, Inc.
    +2.14 pp0.0% → 2.1%History
  2. HNGEHinge Health, Inc.
    +1.97 pp0.6% → 2.5%History
  3. CORTCorcept Therapeutics Inc
    +1.75 pp0.0% → 1.8%History
  4. ALGMAllegro Microsystems, Inc.
    +1.65 pp0.0% → 1.7%History
  5. CVLTCommvault Systems Inc
    +1.55 pp0.0% → 1.5%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. STRLSterling Infrastructure, Inc.
    −$12.8MReducedHistory
  2. FIVEFive Below, Inc
    −$9.74MSold outHistory
  3. PTENPatterson Uti Energy Inc
    −$9.71MSold outHistory
  4. MKSIMKS Inc
    −$8.16MReducedHistory
  5. MTDRMatador Resources Co
    −$7.78MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. FIVEFive Below, Inc
    −2.45 pp2.5% → 0.0%History
  2. PTENPatterson Uti Energy Inc
    −2.45 pp2.4% → 0.0%History
  3. MTDRMatador Resources Co
    −1.96 pp2.0% → 0.0%History
  4. AEISAdvanced Energy Industries Inc
    −1.93 pp1.9% → 0.0%History
  5. FNFabrinet
    −1.60 pp1.6% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$454.6M
+$57.7M (+14.6%) vs. prior quarter
Positions
109
+6 vs. prior quarter
Top 10 concentration
19.1%
Top 10 as share of value
Turnover
50.9%
Q2 2026, one quarter
Average holding period
2.9 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $890.3M (Q1 2022)

Q1 2021: $779.5MQ2 2021: $807.5MQ3 2021: $678.5MQ4 2021: $691.1MQ1 2022: $890.3MQ2 2022: $736.3MQ3 2022: $747.9MQ4 2022: $732.3MQ1 2023: $716.6MQ2 2023: $721.4MQ3 2023: $632.8MQ4 2023: $423.9MQ1 2024: $410.3MQ2 2024: $416.0MQ3 2024: $394.9MQ4 2024: $415.7MQ1 2025: $336.2MQ2 2025: $360.8MQ3 2025: $408.8MQ4 2025: $422.1MQ1 2026: $396.8MQ2 2026: $454.6M
Q1 2021Q2 2026
13F filings of Lisanti Capital Growth, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 10, 2026109$454.6MHNGEBTSGXMTRvs. Q1 2026SEC
Q1 2026May 7, 2026103$396.8MFIVEPTENCRSvs. Q4 2025SEC
Q4 2025Feb 9, 2026110$422.1MFROGCRSLGNDvs. Q3 2025SEC
Q3 2025Nov 4, 2025105$408.8MKTOSSTRLBWXTvs. Q2 2025SEC
Q2 2025Aug 7, 2025106$360.8MCRDOMGNILITEvs. Q1 2025SEC
Q1 2025Apr 25, 2025108$336.2MCORTPLMRANIPvs. Q4 2024SEC
Q4 2024Feb 7, 2025111$415.7MQTWOALABROADvs. Q3 2024SEC
Q3 2024Nov 4, 2024116$394.9MFTAIZETAQTWOvs. Q2 2024SEC
Q2 2024Aug 1, 2024115$416.0MOLLIFRPTQTWOvs. Q1 2024SEC
Q1 2024May 7, 2024117$410.3MMODCNMWFRDvs. Q4 2023SEC
Q4 2023Feb 6, 2024124$423.9MMODNTNXTMDXvs. Q3 2023SEC
Q3 2023Nov 3, 2023117$632.8MGTLSRIGHURNvs. Q2 2023SEC
Q2 2023Aug 11, 2023135$721.4MELFSPXCATECvs. Q1 2023SEC
Q1 2023May 8, 2023108$716.6MPIHURNWINGvs. Q4 2022SEC
Q4 2022Feb 6, 2023122$732.3MFTIINSPWFRDvs. Q3 2022SEC
Q3 2022Nov 2, 2022110$747.9MACHCKNSLGTLSvs. Q2 2022SEC
Q2 2022Aug 3, 2022100$736.3MGTLSITCISITMvs. Q1 2022SEC
Q1 2022May 12, 2022112$890.3MINSPSITMPCRXvs. Q4 2021SEC
Q4 2021Feb 4, 2022116$691.1MBOOTSITMKRNTvs. Q3 2021SEC
Q3 2021Nov 3, 2021129$678.5MSPTGTLSKRNTvs. Q2 2021SEC
Q2 2021Aug 16, 2021130$807.5MSPTASANSGRYvs. Q1 2021SEC
Q1 2021May 12, 2021122$779.5MNUVAGTLSALGT–SEC